Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07323719
What this trial is testing

Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.

Who this might be right for
Atopic Dermatitis (AD)
Cairo University 100
Early research (Phase 1)Study completedNCT06345404
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
Corvus Pharmaceuticals, Inc. 82
Not applicableLooking for participantsNCT04455906
What this trial is testing

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

Who this might be right for
Atopic Dermatitis
Boston Children's Hospital 111
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Testing effectiveness (Phase 2)Active Not RecruitingNCT06176040
What this trial is testing

TAVO101 in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Tavotek Biotherapeutics 20
Early research (Phase 1)Looking for participantsNCT06928246
What this trial is testing

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Daniel Kaplan 8
Early research (Phase 1)Study completedNCT07466940
What this trial is testing

A Clinical Study to Evaluate SM17 in Healthy Participants

Who this might be right for
Atopic DermatitisAsthmaInflammatory Bowel Disease
SinoMab BioScience Ltd 30
Large-scale testing (Phase 3)Study completedNCT05650320
What this trial is testing

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Beijing Research Institute 240
Large-scale testing (Phase 3)Looking for participantsNCT07355075
What this trial is testing

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Who this might be right for
Eczema Atopic DermatitisEczemaAtopic Dermatitis
Turn Therapeutics 190
Not applicableAvailableNCT05466578
What this trial is testing

Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Who this might be right for
Severe Uncontrolled Atopic Dermatitis
Pfizer
Testing effectiveness (Phase 2)Study completedNCT06024499
What this trial is testing

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaAtopic Dermatitis of Scalp
Shaperon 210
Early research (Phase 1)Ended earlyNCT04262791
What this trial is testing

A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
AbbVie 16
Not applicableStudy completedNCT05029895
What this trial is testing

Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
AbbVie 167
Early research (Phase 1)Study completedNCT02496546
What this trial is testing

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
LEO Pharma 30
Testing effectiveness (Phase 2)Study completedNCT02324972
What this trial is testing

Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aquinox Pharmaceuticals (Canada) Inc. 54
Early research (Phase 1)Study completedNCT07205081
What this trial is testing

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Normal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more
Attovia Therapeutics Inc 48
Not applicableStudy completedNCT07742241
What this trial is testing

Efficacy Study of a Repairing Cream in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L. 116
Large-scale testing (Phase 3)Study completedNCT02965118
What this trial is testing

CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amorepacific Corporation 240
Post-approval studies (Phase 4)UnknownNCT04520308
What this trial is testing

An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis

Who this might be right for
Atopic DermatitisADEczema
Eric Simpson 45
Testing effectiveness (Phase 2)Study completedNCT02210780
What this trial is testing

Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 194
Next Page